Leukemia Research
Volume 25, Issue 12 , Pages 1047-1050 , December 2001

Antibody against CD20 in patients with B cell malignancy

  • Penelope J. Adamson

      Affiliations

    • Child Health Research Institute, Women's and Children's Hospital, University of Adelaide, 72 King William Road, Adelaide 5006, Australia
    • Studies carried out as candidate for PhD degree in the Department of Paediatrics, University of Adelaide. Present Address: Department of Microbiology, Flinders Medical Centre, Adelaide, Australia.
    • ,
  • Heddy Zola

      Affiliations

    • Child Health Research Institute, Women's and Children's Hospital, University of Adelaide, 72 King William Road, Adelaide 5006, Australia
    • Corresponding Author InformationCorresponding author. Tel.: +61-8-82047015; fax: +61-8-82390267
    • ,
  • Ian C. Nicholson
    • ,
  • Glenn Pilkington

      Affiliations

    • Intracel Corp., Rockville, MD, USA
    • ,
  • Arthur Hohmann

      Affiliations

    • Child Health Research Institute, Women's and Children's Hospital, University of Adelaide, 72 King William Road, Adelaide 5006, Australia

Received 11 August 2000 ,Accepted 7 April 2001.

References 

  1. Press OW, Eary JF, Appelbaum FR, Martin PJ, Nelp WB, Glenn S, et al.  Phase II trial of 131I-B1 (anti-CD20) antibody therapy with autologous stem cell transplantation for relapsed B cell lymphomas. Lancet. 1995;346:336–340
  2. Reff ME, Carner K, Chambers KS, Chinn PC, et al.  Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20. Blood. 1994;83:435–445
  3. Leget GA, Czuczman MS. Use of rituximab, the new FDA-approved antibody. Curr. Opin. Oncol. 1998;10:548–551
  4. LoBuglio AF, Wheeler RH, Trang J, Haynes A, Rogers K, Harvey EB, et al.  Mouse/human chimeric monoclonal antibody in man: kinetics and immune response. Proc. Natl. Acad. Sci. USA. 1989;86:4220–4224
  5. Vaughan TJ, Williams AJ, Pritchard K, Osbourn JK, Pope AR, Earnshaw JC, et al.  Human antibodies with sub-nanomolar affinities isolated from a large non-immunized phage display library [see comments]. Nat. Biotechnol. 1996;14:309–314
  6. Hoogenboom HR, de Bruine AP, Hufton SE, Hoet RM, Arends JW, Roovers RC. Antibody phage display technology and its applications. Immunotechnology. 1998;4:1–20
  7. Morimoto C, Reinherz EL, Borel Y, Mantzouranis E, Steinberg AD, Schlossman SF. Autoantibody to an immunoregulatory inducer population in patients with juvenile rheumatoid arthritis. J. Clin. Invest. 1981;67:753–761
  8. Chia WK, Blanchette V, Mody M, Wright JF, Freedman J. Characterization of HIV-1-specific antibodies and HIV-1-crossreactive antibodies to platelets in HIV-1-infected haemophiliac patients. Br. J. Haematol. 1998;103:1014–1022
  9. Hohmann AW, Booth K, Peters V, Gordon DL, Comacchio RM. Common epitope on HIV p24 and human platelets [see comments]. Lancet. 1993;20(342):1274–1275
  10. Bettaieb A, Fromont P, Louache F, Oksenhendler E, Vainchenker W, Duedari N, et al.  Presence of cross-reactive antibody between human immunodeficiency virus (HIV) and platelet glycoproteins in HIV-related immune thrombocytopenic purpura. Blood. 1992;80:162–169
  11. Tureci O, Sahin U, Zwick C, Neumann F, Pfreundschuh M. Exploitation of the antibody repertoire of cancer patients for the identification of human tumor antigens. Hybridoma. 1999;18:23–28
  12. Siskind GW. The role of circulating antibody in the control of antibody synthesis: mechanism for the suppressive effect of passive antibody on active antibody synthesis. Transfusion. 1968;8:127–133
  13. Tureci O, Sahin U, Pfreundschuh M. Serological analysis of human tumor antigens: molecular definition and implications. Mol. Med. Today. 1997;3:342–349
  14. Pritsch O, Maloum K, Dighiero G. Basic biology of autoimmune phenomena in chronic lymphocytic leukemia. Semin. Oncol. 1998;25:34–41
  15. Hamblin TJ, Oscier DG, Young BJ. Autoimmunity in chronic lymphocytic leukaemia. J. Clin. Pathol. 1986;39:713–716
  16. Dighiero G. An attempt to explain disordered immunity and hypogammaglobulinemia in B-CLL. Nouv. Rev. Fr. Hematol. 1988;30:283–288
  17. Winfield JB, Fernsten PD, Czyzyk JK. Anti-lymphocyte autoantibodies in systemic lupus erythematosus. Trans. Am. Clin. Climatol. Assoc. 1996;108:127–135
  18. Dourdan P, Labro MT, Bourgeois P, Vinceneux P, Elias I, Kaplan G, et al.  Antinuclear, anti-DNA and anti-lymphocyte antibodies in systemic scleroderma. 62 cases. Rev. Rhum. Mal. Osteoartic. 1983;50:521–524
  19. Einfeld DA, Brown JP, Valentine MA, Clark EA, Ledbetter JA. Molecular cloning of the human B cell CD20 receptor predicts a hydrophobic protein with multiple transmembrane domains. EMBO J. 1988;7:711–717
  20. Tedder TF, Klejman G, Schlossman SF, Saito H. Structure of the gene encoding the human B lymphocyte differentiation antigen CD20 (B1). J. Immunol. 1989;142:2560–2568
  21. Ling NR, MacLennan ICM, Mason DY. B-cell and plasma cell antigens: new and previously defined clusters. In:  McMichael AJ editors. Leucocyte Typing III: White Cell Differentiation Antigens. 3rd edition. Oxford: Oxford University Press; 1987;p. 302–335
  22. Moore DS, McAbe GP. Introduction to the Practice of Statistics. 3rd edition. New York: WH Freeman; 1999;
  23. McMichael AJ, Beverley PCL, Cobbold S, Crumpton MJ, Gilks W, Gotch FM, et al.  Leucocyte Typing III. White Cell Differentiation Antigens. Oxford: Oxford University Press; 1987;
  24. Guilbert B, Dighiero G, Avrameas S. Naturally occurring antibodies against nine common antigens in human sera. I. Detection, isolation and characterization. J. Immunol. 1982;128:2779–2787
  25. Bender E, Pilkington GR, Burton DR. Human monoclonal Fab fragments from a combinatorial library prepared from an individual with a low serum titer to a virus. Hum. Antibodies Hybridomas. 1994;5:3–8

PII: S0145-2126(01)00074-1

Leukemia Research
Volume 25, Issue 12 , Pages 1047-1050 , December 2001

Article Tools

* Image Usage & Resolution